HIKMA Pharmaceuticals PLC — Director's Dealing 2017

Apr 28, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7250D

Hikma Pharmaceuticals Plc

28 April 2017

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Michael Raya
2	Reason for the notification
a)	Position/status	CEO of West-Ward Pharmaceuticals
b)	Initial notification /Amendment	Amendment
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Purchase of 10,272 shares in the Company in compliance with the Company's shareholding requirement.
c)	Price(s) and volume(s)	Price(s): £18.689 Volume(s): 10,272
d)	Aggregated information	Price(s): £18.689 Volume(s): 10,272 Total: £191,973.41
e)	Date of the transaction	26 April 2017
f)	Place of the transaction	London Stock Exchange (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBDGDSUUDBGRI